Physician profile
Kristopher Whitehead
NPI 1700057106
$16,696.74
in general payments reported to CMS, 2019-2025
49 companies · $5,586 in 2025
The $5,586 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,184 · 2020: $927 · 2021: $739 · 2022: $5,047 · 2023: $1,427 · 2024: $1,787 · 2025: $5,586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,800 · Education: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,799.62 |
| Education | $4,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,190.00 | 2019-2025 | |
| Boston Scientific Corporation | $2,853.32 | 2019-2025 | Tria Firm, Lithovue, Lumenis Pulse 120h |
| Janssen Biotech, INC. | $826.32 | 2019-2025 | Erleada, Akeega, Carvykti |
| Abbvie INC. | $811.40 | 2019-2025 | Botox |
| Sumitomo Pharma America, INC. | $455.07 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $416.46 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $310.44 | 2019-2025 | Provenge |
| Endo Pharmaceuticals INC. | $255.74 | 2021-2024 | Aveed, Xiaflex, Edex |
| Neotract INC. | $242.13 | 2019-2020 | |
| Urogen Pharma, INC. | $227.06 | 2020-2025 | Jelmyto |
| Procept Biorobotics Corporation | $186.29 | 2019-2024 | Aquabeam System, Aquabeam Robotic System |
| Axonics, INC. | $184.81 | 2020-2023 | Axonics |
| Pfizer INC. | $184.30 | 2019-2025 | |
| Olympus America INC. | $145.71 | 2019-2025 | Itind System, Soltive |
| Myriad Genetic Laboratories, INC. | $115.88 | 2023-2024 | Prolaris |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $106.61 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Endo USA, INC. | $84.15 | 2024-2025 | Xiaflex, Aveed |
| Medtronic, INC. | $72.85 | 2023-2025 | Interstim, Nuro |
| Novartis Pharmaceuticals Corporation | $71.67 | 2020-2025 | |
| Baxter Healthcare | $68.53 | 2021 | |
| Allergan, INC. | $68.21 | 2020-2022 | |
| Urovant Sciences INC | $56.62 | 2022 | |
| Myovant Sciences INC. | $54.38 | 2022 | |
| Srs Medical Systems, INC. | $48.33 | 2019 | |
| Coloplast Corp | $46.41 | 2021-2023 | Porges Coloplast |
| Rochester Medical Corporation | $43.21 | 2021 | |
| Merck Sharp & Dohme LLC | $43.10 | 2021-2023 | Lynparza, Keytruda |
| Alnylam Pharmaceuticals INC. | $41.26 | 2023 | Oxlumo |
| Bayer Healthcare Pharmaceuticals INC. | $41.02 | 2019-2021 | |
| Blue Earth Diagnostics | $37.42 | 2021-2022 | |
| Halozyme INC | $36.75 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $34.83 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $32.86 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Tolmar, INC. | $32.08 | 2024 | |
| Amgen INC. | $31.67 | 2020-2021 | |
| Travere Therapeutics, INC. | $27.68 | 2020 | |
| Laborie Medical Technologies Corp. | $27.41 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Clarus Therapeutics INC. | $23.58 | 2021 | |
| Accord Healthcare, INC. | $20.29 | 2023 | |
| Millicent US INC | $19.08 | 2024 | Femring, Intrarosa |
| Ethicon US, LLC | $18.37 | 2022 | |
| Ferring Pharmaceuticals INC. | $18.19 | 2025 | Adstiladrin |
| Vertex Pharmaceuticals Incorporated | $18.03 | 2025 | |
| Teleflex LLC | $15.77 | 2021 | |
| Lsi Solutions INC | $14.46 | 2024 | Jnw Urtrac, Ti-Knot, Running Device |
| Ambu INC. | $13.52 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $13.25 | 2021 | |
| Allegis Pharmaceuticals, LLC | $10.22 | 2023 | Urimar-T Caps |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$14,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Whitehead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.